Estimated Value
Up to £200,000,000
Deadline
Not specified
Published
12 May 2025
Type
services
Overview
The Trust has worked with a commercial partner in a joint venture (JV) arrangement to deliver a comprehensive pathology service for the last 10 years. Building on this knowledge and experience, the Trust was looking for a new partner that matches its ambitions.
The initial term of the pathology service JVwill be for a period of fifteen (15) years with an option to extend by up to five (5) years. The Trust was looking for a partner that will; • Provide an exceptional, high-quality service that meets the specialist needs of a comprehensive cancer centre; • Provide investment for the provision of world class infrastructure; • Embrace the exciting opportunities presented with the co-location of a world leading oncology research centre; and • Provide expert guidance along with the creativity and drive to deliver a modern, thriving, truly exceptional pathology service for patients.
The current pathology service provides routine and specialist pathology services with c100 dedicated staff on The Christie Hospital site. The service includes translational biomarker development and supports the Trust’s ambitious Research and Innovation (R&I) programme and clinical trials portfolio.
Principles/Objectives The Future Pathology Service should reflect the following principles/objectives
- Safe, effective, and responsive to the diversity of patient and clinical needs and offers the specialist and integrated pathology services needed to support a regional tertiary cancer centre.
- Delivery of a sustainable future pathology workforce
- alignment with the Trust’s Vision and Values and the objectives of Greater Manchester Cancer.
- Commitment to working as part of Greater Manchester ICS in the delivery of the Core20PLUS5 programme to support the reduction of health inequalities at both national and system level.
- Enabled by a strong digital infrastructure and capability. Adopting digital opportunity and technology advances to deliver more efficient and scalable pathology services.
- A service model that considers The Trust’s local, regional national and international partnerships, including engagement with the Greater Manchester Pathology Network to explore opportunities to support system requirements.
- Delivered through a partnership that has a strategy for profitable growth through expanding test repertoire and customer base.
- Builds upon the Trust’s reputation as an international leader in research and innovation, which is further strengthened by being a partner in the Manchester Cancer Research Centre (MCRC) and Health Innovation Manchester.
- A service with capital investment to provide best in class facilities.
- A service that has education at its core.
The Future Operating Model for Pathology must include
- An end-to-end comprehensive pathology service
- Blood sciences including haematology, blood transfusion, clinical biochemistry and immunoassay
- On-site essential services laboratory to support time critical and pathway critical services
- Histopathology (including immunohistochemistry and receptor analysis)
- Stem Cell Laboratory
- Point-of-Care Testing
- A future-proof design with activity growth in service expectation factored in – including expansion of on-site and off-site facilities to meet projected demand;
- An agile approach that can respond to evolving technology and operational requirements and provide improvements to the Trust Pathology Estate;
- Training, Development and Education, Research and Innovation
- Positive workplace culture
- IT infrastructure and digital enablement (including Digital Histopathology)
- Best in class equipment and instrumentation
Details
- Vision
- To provide a world leading comprehensive pathology service that supports timely and highquality delivery of patient care - regionally and nationally - and develops an internationally recognised workforce who, with academic and industry partners, deliver a pioneering programme of research and innovation.
Additional details
Demand for testing is increasing year on year reflecting the Trust’s oncology case load. The Trust sought a JV pathology partner who is able to deliver the Trust’s strategic ambitions, including accommodation of projected testing growth demand and flexible options for the development of facilities, estate, technology, and changes in clinical pathways.
AI AnalysisMembers
Requirements, key tasks and tips for reading this tender — included with Tendarix membership.
£4.99/month after a 7-day free trial. Cancel anytime before it ends and you pay nothing.
Award Details
SYNLAB
£200,000,000
Before you bid, buyers check
two years of filed accountsyour financial standingturnover vs contract valueyour Companies House recordcash flow for 30-day termscredit scores and ratios
Actions
Start free trialto open noticeCreate an account and start a 7-day free trial to open the buyer’s own notice and tender documents, plus fit scoring and the Bid Writer. Then £4.99/month — cancel anytime.
Open Bid WriterIndependent software, web & cloud studio. We design, build and grow digital products that quietly outlast their category.
How to Apply
Step-by-step submission guide
Submission Portal
Find a Tender
Open the original notice
Click the button below to view the full notice on Find a Tender Service (FTS)
Check the procedure type
The "Procedure" section tells you if it's Open (one stage) or Restricted (SQ then ITT). This changes how you apply
Access the eSourcing portal
FTS notices link to the buyer's eSourcing platform — register there to access documents
Complete the Selection Questionnaire
Higher-value contracts often require an SQ first — this pre-qualifies you before the full bid stage
Submit electronically
Upload your completed response through the eSourcing platform before the closing date and time
FTS contracts are above UK procurement thresholds. Late submissions are strictly rejected — submit at least 24 hours before the deadline to avoid portal issues.
Buyer Profile
The Christie NHS Foundation TrustKey Dates
Published
12 May 2025
Submission deadline
Not specified
Notice type
award
Source
find a tender
Related Tenders
Non-planar surface characterisation and swabbing using the spot robot
The Contractor’s scope shall include the design, development, functional demonstration, and delivery (including all required testing, verification, and documentation) of the Spot s
Neurodevelopmental support for children, families and professionals
The NHS Cheshire and Merseyside ICB will directly award a three‑year contract to the current provider to deliver neurodevelopmental support for children, families and professionals dealing with ADHD or ASD across Liverpool, Sefton, Wirral, St Helens, Knowsley, Halton and Warrington.
Provision of occupational health services
The Trust requires a minimum of two Occupational Health Physicians/Providers for a 3- year term from the 1st January 2027 with a 2-year extension option. This contract is for the p
WCST01.27 - westcountry schools trust - CAFM system
WeST operates 31 schools serving approximately 15,000 pupils and employing approximately 2,300 staff. The estate comprises 23 primary schools and 8 Secondary schools, the largest o